Average Co-Inventor Count = 9.03
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (15 from 3,923 patents)
2. Massachusetts Institute of Technology (4 from 8,369 patents)
3. Other (1 from 832,680 patents)
4. Astex Therapeutics Limited (1 from 123 patents)
20 patents:
1. 12429630 - Multifunctional metasurface flat optics
2. 12405400 - Methods and systems for metasurface-based nanofabrication
3. 12122761 - 2-azaspiro[3.4]octane derivatives as M4 agonists
4. 11905283 - Compounds and compositions for inhibiting the activity of SHP2
5. 11850001 - Meta-optics-based systems and methods for ocular applications
6. 11820778 - 2-azaspiro[3.4]octane derivatives as M4 agonists
7. 11548865 - 2-azaspiro[3.4]octane derivatives as M4 agonists
8. 11485742 - 2-azaspiro[3.4]octane derivatives as M4 agonists
9. 11206978 - Meta-optics-based systems and methods for ocular applications
10. 10934285 - Compounds and compositions for inhibiting the activity of SHP2
11. 9309252 - Pyrrolopyrimidine compounds as inhibitors of CDK4/6
12. 8957068 - 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
13. 8957074 - Pyrrolopyrimidine compounds as inhibitors of CDK4/6
14. 8598217 - Imidazole derivatives and their use as modulators of cyclin dependent kinases
15. 8552003 - (S)-N-((S)-1-cyclohexyl-2-{(S)-2-[4-4-(4-fluorobenzoyl)-thiazol-2-yl]pyrrolidin-1-yl}-2-oxoethyl)-2-methylamino-propionamide, or pharmaceutically acceptable salts thereof and their uses